left space About Us Product Candidates Newsroom Investor Information Business Development

IDDS logo
c Investors Information
left space Overview   Governance   SEC Filings   News Releases   Stock Quote   FAQs   Events   Email Notification   Investor Kit    Snapshot

pixel shim

SEC Filings

     
 
Filing Date Sorted Descending Filing Description Size
7/1/2008 4 watson, douglas g 23.6 KB
6/27/2008 4 watson, douglas g 23.6 KB
6/27/2008 4 mermelstein, fred h 23.7 KB
6/26/2008 4 driscoll, martin j 23.7 KB
6/6/2008 8-K current report 37.0 KB
6/5/2008 8-K current report 140.3 KB
6/4/2008 ARS annual report to security holders 0.0 KB
5/22/2008 SC 13G statement of beneficial ownership 65.2 KB
5/15/2008 4 davidson, charles e 27.4 KB
5/15/2008 4 carr, daniel b 23.7 KB
5/15/2008 4 driscoll, martin j 23.7 KB
5/15/2008 4 flanzraich, neil 23.6 KB
5/12/2008 10-Q quarterly report 269.6 KB
5/9/2008 424B5 prospectus filed pursuant to rule 424 575.1 KB
5/9/2008 8-K current report 281.8 KB
4/29/2008 DEF 14A definitive proxy statement 406.9 KB
4/11/2008 S-8 registration statement 82.1 KB
3/14/2008 S-8 registration statement 340.1 KB
3/14/2008 10-K annual report 1.1 MB
3/7/2008 8-K current report 63.9 KB
Showing 1-20 of 252 filings Page: 1 2 3 4 5 6 7 8 9 10 11 12 13  See Next 20
 

 

CONTACT US   JOIN US   SITE MAP
© 2008 Javelin Pharmaceuticals,Inc. / Intrac,Inc. / IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.